Market Entry
International → China · China → Global
Market assessment, prioritisation, regulatory pathway, clinical access, localisation and go-to-market strategy.
Healthcare · Cross-border · Execution
We help healthcare companies enter new markets, build strategic partnerships and execute cross border growth.

What we do
Senior, evidence-aware support for healthcare companies moving across borders.
International → China · China → Global
Market assessment, prioritisation, regulatory pathway, clinical access, localisation and go-to-market strategy.
Relationships with a reason to exist
Strategic partner mapping, distributor development, hospital and KOL access, channel development and negotiation support.
Structures that move a programme forward
Licensing, distribution, joint ventures, co-development, commercial partnerships and transaction structuring.
Why Haoyi
We bring scientific understanding, commercial judgement and China execution depth to the moments that matter.
01
Scientific and commercial understanding across MedTech and healthcare innovation.
02
Market entry, partner development and commercial transaction capabilities.
03
Senior level involvement throughout every engagement.
China Market Access Network
Public-sector, park and market-access relationships are assessed project by project, with current terms confirmed before action.






Start a conversation
Tell us where you are going, what is blocking progress and what a useful conversation would need to unlock.
[email protected]